Genetics

This blog post examines research by Zhang and colleagues investigating how lipid-related genetic polymorphisms may influence disability progression in multiple sclerosis (MS). Using longitudinal clinical, genetic, and metabolic data, the study found that a cumulative genetic risk score based on lipid-associated variants was linked to faster increases in neurological disability and significantly modified the relationship between serum lipid levels and disease progression. In particular, lower high-density lipoprotein (HDL) concentrations and higher total cholesterol-to-HDL ratios were associated with greater disability progression among individuals carrying a higher number of genetic risk alleles. The findings highlight the complex interaction between inherited susceptibility and metabolic factors in MS and suggest that integrating genetic and lipid profiles could contribute to improved prognostic models and, following further validation, more personalised approaches to disease management.